Today, Benzinga 's options scanner spotted 41 uncommon options trades for Marvell Tech. This isn't normal. The overall ...

SBC Leaders speaks to Evoke Chief Executive Officer Per Widerström and Chief Strategy Officer Vaughan Lewis about one of the ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Barclays PLC raised its position in Astec Industries, Inc. (NASDAQ:ASTE – Free Report) by 118.9% during the third quarter, ...

Wall Street banks like Barclays and Citigroup embrace crypto, earning $200M in fees from capital-raising deals tied to ...

Rollins (NYSE:ROL – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note ...

Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.

Crown Castle Inc (CCI) stock saw a decline, ending the day at $90.56 which represents a decrease of $-0.58 or -0.64% from the prior close of $91.14. The stock opened at $90.75 and touched a low of $90 ...

Shell plc, known as Royal Dutch Shell, boasts a market cap of almost $200 billion, making it a significant player in the ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

Barclays analyst Nicholas Campanella maintained a Buy rating on Entergy (ETR – Research Report) on December 24 and set a price target of ...

In a report released on December 23, David Anderson from Barclays maintained a Hold rating on Halliburton (HAL – Research Report), with a price ...